Home | Welcome to Contract Pharma   
Last Updated Saturday, November 1 2014
Print

Savient Appoints Co-Presidents



Published June 21, 2013
Savient Pharmaceuticals, Inc. has appointed Richard Crowley as co-president and chief operating officer, John P. Hamill, who will serve as co-president and chief financial officer, and Philip K. Yachmetz, who will serve as co-president and chief business officer. Louis Ferrari, president, chief executive officer, and director, is leaving the company to pursue other interests.
 
The board of directors thanks Mr. Ferrari for his valuable contributions throughout his tenure and wishes him well in his future endeavors.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On